Merck & Company Inc

Stock Chart, Company Information, and Scan Results

$115.48(as of Jun 22, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Merck & Company Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$115.48
Ticker SymbolMRK
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees73,000
CountyUSA
Market Cap$281,238.9M
EBIDTA29,517.0M
10-Day Moving Average116.86
P/E Ratio31.95
20-Day Moving Average117.38
Forward P/E Ratio22.52
50-Day Moving Average114.80
Earnings per Share3.55
200-Day Moving Average104.04
Profit Margin-26.03%
RSI48.61
Shares Outstanding2,469.8M
ATR3.08
52-Week High123.33
Volume10,519,135
52-Week Low74.18
Most Recent Support Level111.57
Book Value45,931.0M
Most Recent Resistance Level115.99
P/B Ratio6.22
Upper Keltner124.32
P/S Ratio4.35
Lower Keltner110.45
Debt-to-Equity Ratio124.32
Next Earnings Date08/04/2026
Cash Surplus-21,618.0M
Next Ex-Dividend DateUnknown

This pharmaceutical company is responsible for one of the best-selling drugs worldwide. Their blockbuster drug, Keytruda, is designed to treat certain types of cancer and is the company’s main revenue driver. They are also behind the development of Gardasil—a vaccine for HPV that has helped prevent hundreds of thousands of cases of cervical cancer.

Merck & Company Inc In Our Stock Scanner

As of Jun 23, 2026
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.